More on PHVS

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (11/18/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Pharvaris (NQ:PHVS)
Delayed: 31.69 +0.28 (0.89%)
Prev. Close $31.41  
Open$31.38 
52 Wk High$ 
52 Wk Low$ 
Day High$32.08 
Day Low$31.30 
P/E N/A  
EPS$ 
Volume173,280 

Friends, Peers and Foes (?): ABBV, ACAD, ARWR, ASND, BCRX (more...)

Oct 23, 2026 06:04 AM BofA Securities Upgrades Pharvaris B.V. (PHVS) to Buy
Oct 13, 2026 04:11 PM Form 4 Pharvaris N.V. For: Oct 11 Filed by: Lu Peng
Oct 8, 2026 06:35 PM Pharvaris publishes phase 3 deucrictibant HAE study results in The Lancet
Oct 8, 2026 06:35 PM Phase 3 Study Results Highlighting Deucrictibant’s Rapid and Sustained Efficacy in Treating HAE Attacks Published in The Lancet
Oct 6, 2026 06:56 AM H.C. Wainwright Reiterates Buy Rating on Pharvaris B.V. (PHVS)
Oct 5, 2026 06:50 AM Real-World Analysis Highlighting HAE Disease Experience and Gaps in Treatment Satisfaction Published in Advances in Therapy
Sep 25, 2026 01:36 PM Form 4 Pharvaris N.V. For: Sep 23 Filed by: Monges Viviane
Sep 24, 2026 04:03 PM Form 4 Pharvaris N.V. For: Sep 22 Filed by: Lu Peng
Sep 24, 2026 10:43 AM Form 4 Pharvaris N.V. For: Sep 22 Filed by: Schikan Johannes Gerardus Christiaan Petrus
Sep 23, 2026 04:24 PM Form 144 Pharvaris N.V. Filed by: Monges Viviane
View All Articles

Entities mentioned with PHVS

View All Entities